Target intelligence / Profile preview

RN7SK pseudogene 221 (RN7SKP221)

Target
RN7SKP221
Molecular classification
Other (pseudogene; not a protein-coding gene, receptor, enzyme, transporter, transcription factor, etc.)
01

Overview

RN7SK pseudogene 221 (RN7SKP221) is classified as a pseudogene, which means it is a genomic sequence similar to the functional RN7SK gene but lacks the ability to produce a functional RNA or protein product. Pseudogenes generally result from gene duplication or retrotransposition and acquire disabling mutations that prevent their expression or function. There is currently no evidence that RN7SKP221 acts as a receptor, enzyme, transporter, or any other pharmacologically actionable molecule. RN7SKP221 should not be confused with the functional RN7SK gene (small nuclear RNA 7SK), which has important roles in transcriptional regulation and immune functions, but the pseudogene itself is not considered a therapeutic target nor does it play a role in disease states or drug interactions[3][5]. The entry "RN7SKP221" is incorrect or incomplete for therapeutic target analysis, as it refers to a non-functional pseudogene. If you intended to reference the functional molecule, you should search for "RN7SK small nuclear RNA" or "small nuclear RNA 7SK" instead.

Other names
RN7SKP221

Beyond the preview

Go deeper on RN7SK pseudogene 221 (RN7SKP221).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 221 (RN7SKP221).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call